Versant Voyageurs I Parallel, L.P., 10% Owner at Black Diamond Therapeutics, Inc. (BDTX), sold 25,976 shares at $33.08 ($859K) on 2020-08-11, disclosed to the SEC on 2020-08-12.
Scheduled sale ($859k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.04 | 725 | $24K | 2.8% |
| 2 | $33.04 | 5,492 | $181K | 21.1% |
| 3 | $33.04 | 5,492 | $181K | 21.1% |
| 4 | $33.08 | 883 | $29K | 3.4% |
| 5 | $33.08 | 6,692 | $221K | 25.8% |
| 6 | $33.08 | 6,692 |
| $221K |
| 25.8% |
| Total | $33.06 avg | 25,976 | $859K | 100% |
| Filing → |
| BDTX | SELL | 2020-11-19 | $279K | — | Filing → |
| BDTX | SELL | 2020-10-20 | $992K | — | Filing → |
| BDTX | SELL | 2020-10-15 | $1.1M | — | Filing → |